Blood Sugar & Glucose Tracking vs epocrates: Drug Info & Pill ID
A data-backed head-to-head — estimated revenue, downloads, ratings and pricing side by side, from live App Store signals. Updated continuously.
Revenue / mo
$200–$1k
$310k–$1.3M
Downloads / mo
200–1k
280k–1.2M
Rating
★ 4.33 (323)
★ 4.46 (7k)
Pricing
Free + IAP
Free + IAP
Category
Medical
Medical
Released
1.6y ago
7.3y ago
Verdict: epocrates: Drug Info & Pill ID earns more — an estimated $310k–$1.3M/mo, versus $200–$1k/mo for Blood Sugar & Glucose Tracking.